Results 121 to 130 of about 98,054 (191)

Minimum caseload for cost-effective robotic-assisted surgery: a systematic review. [PDF]

J Robot Surg
Garavini AB, de Carvalho Veludo AC, Alexander K, Cotte J, Leslie S, Thanigasalam R, Pereira LSM, Lage APD, Arnaiz KF, Steffens D.   +9 more
europepmc   +1 more source

Nivolumab plus ipilimumab versus lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma: A cost-effectiveness analysis. [PDF]

Cancer
Luo J, Li Z, Ge J, Cai S, Mo X, Liu W, Gui C, Du Q, Liu J.   +8 more
europepmc   +1 more source

Economic evaluation of single-inhaler triple therapy for chronic obstructive pulmonary disease in Thailand. [PDF]

BMJ Open Respir Res
Dilokthornsakul P, Dilokthornsakul P, Chongmelaxme B, Niyompattama A.   +3 more
europepmc   +1 more source

A cost-effectiveness analysis comparing pembrolizumab combined with chemotherapy versus chemotherapy alone for advanced biliary tract cancer: US and China perspectives. [PDF]

PLoS One
Zhang C, Liang H, Qin Y, Tan X, Su X, Tian X, Nong Y.   +6 more
europepmc   +1 more source

A Review of Dementia Caregiver Interventions: Valuing Psychological Well-Being and Economic Impact Through the State-Preference Method. [PDF]

Int J Environ Res Public Health
Consiglio A, Lopez A, Bosco A.
europepmc   +1 more source

Economic value and clinical association of a supervised lifestyle-improving program for MASLD. [PDF]

Front Pharmacol
Polignano M, Bianco A, Guido D, Trisolini P, Franco I, Bonfiglio C, Giannelli G.   +6 more
europepmc   +1 more source

Immune checkpoint inhibitor-based first-line therapies for advanced or unresectable hepatocellular carcinoma: a network meta-analysis and cost-effectiveness analysis. [PDF]

Ther Adv Med Oncol
Qi H, Huang Y, Zhang W, Li J, Wang T, Ying Y, Chen B, Miao F, Li Q.   +8 more
europepmc   +1 more source

Cost-effectiveness of cabozantinib versus placebo for advanced neuroendocrine tumors from crossover-adjusted analysis in the United States and China. [PDF]

Sci Rep
Lang W, Huang B, Zhang G, Deng L, Lu H, Lu M, Pan Y.   +6 more
europepmc   +1 more source

Cost-effectiveness analysis of low bone mass prevention in Chinese older men with excessive alcohol consumption: a modelling study. [PDF]

BMJ Open
Lin X, Liu J, Wang L, Liu T, Zhang Y, Moriwaki K, You R.   +6 more
europepmc   +1 more source